Plausible effects of sodium-glucose cotransporter-2 inhibitors on adverse cardiac remodelling
| dc.contributor.author | Berezin, A. E. | |
| dc.contributor.author | Березін, Олександр Євгенійович | |
| dc.date.accessioned | 2022-03-29T11:50:55Z | |
| dc.date.available | 2022-03-29T11:50:55Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Adverse cardiac remodelling is a common characteristic of abnormalities of cardiac structure and functions, which are a result of natural evolution of numerous cardiovascular disease and other conditions, such as type 2 diabetes mellitus. The pathogenesis of adverse cardiac remodelling is complex and closely relates to the occurrence of heart failure. | uk_UK |
| dc.identifier.citation | Berezin A. E. Plausible effects of sodium-glucose cotransporter-2 inhibitors on adverse cardiac remodelling / A. E. Berezin // European Journal of Preventive Cardiology. - 2021. -P. zwab203. - https://doi.org/10.1093/eurjpc/zwab203. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/16300 | |
| dc.language.iso | en | uk_UK |
| dc.title | Plausible effects of sodium-glucose cotransporter-2 inhibitors on adverse cardiac remodelling | uk_UK |
| dc.type | Article | uk_UK |